At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 26 enrolled
Drug / intervention
Tretinoin gel +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Investigator-Blind, Phase 4 Study Assessing the Facial Irritation Potential of Two Acne Treatment Products Using A Split-Face Model
In Brief
A Phase 4 clinical trial evaluating Tretinoin gel and Adapalene and Benzoyl peroxide for Acne Vulgaris. Completed, enrolled 26 participants across 1 site.
Detailed Summary
A study to compare the skin irritation potential of two marketed gels for acne treatment, each applied to half of the face of healthy volunteers.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne Vulgaris
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartApr 2009
Primary CompletionMay 2009
First PostedJun 2009
TodayJul 2026
First PostedJun 12, 2009
Enrollment StartApr 1, 2009
Primary CompletionMay 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 17.1 years ago
Interventions
Tretinoin geldrug
Tretinoin gel 0.04% used once daily in a split-face model
Adapalene and Benzoyl peroxidedrug
Adapalene .1% and Benzoyl peroxide 2.5%